 initi coverag buy rate
messag initi coverag teladoc buy rate
price target believ telemedicin still earli stage penetr
compani well posit benefit broader trend
appreci competit pressur face industri believ recent pullback
manag visibl could set share beat-and-rais stori
year price target base assumpt share trade
ev/sal
bottom line initi coverag teladoc buy rate
price target believ compani recent product geograph expans
strengthen competit posit open new set growth opportun
acceler adopt also encourag continu shift digit platform
enhanc market drive oper leverag model although
appreci potenti long-term competit risk unlik market
receiv meaning updat front selling-season commentari later year
interim believ reason guidanc manag visibl
subscript model could lead beat-and-rais stori attract setup follow
pullback septemb peak sinc vs
invest posit highlight follow invest posit broad suit
product help differenti offer subscript model creat favor setup
shift digit could drive better financi profil propos chang medicar
advantag potenti expand market opportun
invest risk highlight follow invest risk rel low barrier
entri shift variable-bas contract could impact profit visibl execut
risk follow seri acquisit lofti expect valuat
valuat price share current trade ev/sal
price target base assumpt share trade ev/sal
premium hcit peer univers believ warrant base
robust top-lin growth rate introduc revenu estim
respect given price target assum share could appreci
believ buy rate appropri
page analyst certif import disclosur
teladoc one world largest telehealth platform focus provid on-demand access physician phone
internet time teladoc client consist direct employ health plan hospitals/health system initi compani
focus gener medicin low acuiti treatment case recent acquisit expans cover condit
across much wider rang complex frequenc includ behavior health dermatolog sexual health second opinion
addit teladoc recent acquir sever intern platform increas relev multi-n employ initi
presenc new region list recent acquisit capabl ad platform
betterhelp acquir januari ad specialti capabl behavior health
healthiesty acquir june ad patient engag capabl mobil app provid user person
best doctor acquir june offer second opinion expert consult primarili focus condit higher
complex less frequenc compar teladoc tradit offer
advanc medic acquir june offer servic similar teladoc current offer roughli compani
revenu come intern
teladoc gener revenu primarili subscript access fee visit fee histor contract larg base per-
member-per-month pmpm fee visit fee time contract evolv featur visit includ pmpm
visit fee structur contract uniqu client project around util save health system market
teladoc also licens softwar privat label
broad suit product help differenti offer past sever year teladoc close sever acquisit
broaden product offer consider expand compani reach intern acquisit betterhelp
healthiesty best doctor name integr divers set solut one platform includ behavior health
patient engag second opinion think import sever reason first believ broader address
import drive util member engag varieti use case addit market gener low
barrier entri heavi competit think help differenti teladoc offer justifi favor price model
relat note teladoc meaning intern presenc believ make offer attract multi-n
employ margin posit sell season go forward platform continu integr
subscript model creat favor setup believ high level revenu visibl help limit volatil busi
year major teladoc revenu gener subscript per-member-per-month pmpm basi
gener solidifi prior sell season allow compani comfort manag expect begin
year earn confer call manag claim visibl revenu rang visibl
could creat beat-and-rais setup current year help share gain momentum acknowledg potenti price
diminish time shift variable-bas structur anticip meaning commentari front near term
would look compani results/analyst day fall next opportun learn chang price environ
time believ visit fee structur primarili appli contract compani comfort drive
suffici util comfort manag commentari sell season strongest
shift digit drive better financi profil teladoc continu move toward digit platform believ compani
reap benefit scalabl manag highlight fall analyst day request come
mobil app websit limit need staf call center lower cost serv larger membership addit
initi setup new client requir heavi market rais awar platform repeat usag come materi lower
acquisit cost drive oper leverag either lower expens justifi higher subscript fee util
 side also think compani room run integr oper recent acquisit time opportun
start show financi mark transit compani posit adjust ebitda year
gener adjust ebitda look forward compani guid adjust ebitda roughli
increas near bottom end rang includ certain strateg invest year support growth
addit compani said expect cash flow posit first time appreci focu like continu
revenu near term encourag see earli sign oper leverag
propos chang potenti expand market opportun octob propos chang modern
medicar advantag part expand telehealth access patient propos allow plan broader flexibl
coverag telehealth benefit paid meet need enrolle medicar beneficiari becom tech savvi
work promot beneficiari access telehealth medicar fee-for-servic program telehealth benefit narrowli defin
includ restrict beneficiari receiv care via telehealth locat propos rule would give plan
page analyst certif import disclosur
flexibl offer government-fund telehealth benefit enrolle whether live rural urban area would also allow
greater abil enrolle receiv telehealth place like home rather requir go health care facil
receiv telehealth servic plan would also greater flexibl offer clinically-appropri telehealth benefit otherwis
avail medicar beneficiari propos chang plan year would leverag new author provid
bipartisan budget act presid trump sign law although difficult quantifi believ creat new
market opportun telehealth industri gener increment enthusiasm investor
rel low barrier entri teladoc built strong product portfolio technolog platform network client
provid appreci industri rel low barrier entri technolog perspect believ mani
player alreadi could eventu creat similar platform within healthcar space broader technolog
univers note compani googl amazon express
interest healthcar past telemedicin could potenti point entri busi health system health plan
employ regulatori consum awar perspect teladoc actual help pave way industri whole
improv oper said think teladoc advantag larg physician network broad solut set
given robust growth rate consensu anticip chang competit landscap price hinder perform
could meaning influenc share
shift visit-fee-onli vfo variable-bas contract could impact profit visibl current major teladoc
revenu come subscript access fee highli visibl begin year recent number contract
either shift visit-fee-onli structur client pay pmpm manag believ
contract could provid sourc upsid think investor look less favor upon contract structur could bring
risk volatil teladoc busi model expect industri whole continu transit toward variable-bas
contract time given still rel nascent stage util howev transit like take time develop teladoc
appear perform line better expect current vfo contract give us comfort near term
execut risk follow seri acquisit mention quit acquisit last sever year
broaden platform expand compani geograph reach notabl recent advanc medic deal mark signific
step teladoc given intern presenc deepen recent acquisit medecindirect franc
prior acquisit best doctor also mark meaning transit go-to-market strategi still rel new
acquisit may ultim prove success worth note still plenti execut need take
place form integr togeth without significantli disrupt oper remain seen come
quarter year manag good track record expand platform help mitig risk trend
integr worth monitor
lofti expect valuat manag point long-term growth rang top line appreci
emb robust perform membership growth util time believ teladoc continu execut high
level number industri tailwind support growth appreci littl room error extent believ
teladoc valuat lift view industri still nascent stage penetr long runway ahead
concern util reach ceil major hurdl could signific impact stock think sentiment
name could volatil other hcit space
share current trade revenu price target base assumpt share
trade ev/revenu sale repres premium tdoc histor averag multipl believ
warrant given stronger competit posit market opportun follow seri acquisit past year
also reflect signific premium hcit peer typic trade ev/revenu low double-digit revenu growth
believ warrant given significantli higher top-lin growth rate long runway industri penetr visibl busi
model key risk signific downsid would acceler rise competit put pressur price switch
page analyst certif import disclosur
issu research report guggenheim secur llc guggenheim secur research analyst whose name appear report
herebi certifi view express report accur reflect research analyst person view subject
secur issuer discuss herein ii part research analyst compens directli indirectli relat specif
recommend view express research analyst
research analyst research associ receiv compens base upon variou factor includ qualiti research investor client
feedback guggenheim secur llc overal revenu includ invest bank revenu
guggenheim secur llc affili expect receiv intend seek compens invest bank servic
inc next month
pleas refer websit company-specif disclosur referenc report http //guggenheimsecur bluematrix com/sellside/
disclosur action disclosur inform also avail complianc madison avenu new york ny
rate price target histori inc
creat bluematrix
buy describ stock expect provid total return price appreci plu yield within period
neutral describ stock expect provid total return price appreci plu yield plu minu within
sell describ stock expect provid total neg return price appreci plu yield within period
nr invest rate price target temporarili suspend suspens complianc applic regul and/or
cs coverag suspend guggenheim secur llc suspend coverag compani
nc cover guggenheim secur llc cover compani
monitor describ stock whose compani fundament financi monitor financi project opinion
invest merit compani provid
review ur follow releas signific news compani rate temporarili place review suffici
inform obtain assess analyst
guggenheim secur llc methodolog assign rate may includ follow market capit matur growth/valu volatil
expect total return next month price target base sever methodolog may includ restrict analys
market risk growth rate revenu stream discount cash flow dcf ebitda ep cash flow cf free cash flow ev/ebitda price-to-earnings pe/growth
price-to-cf p/fcf premium discount /averag group ev/ebitda premium discount /averag group price-to-earnings sum part net asset valu dividend return
return equiti roe next month
price target assign buy- sell-rat stock price target neutral-r stock provid discret analyst
page analyst certif import disclosur
